Extensive Biopsy Protocol Improves the Detection Rate of Prostate Cancer

Autor: Vincent Ravery, Laurent Goldblatt, Benoit Royer, et al.
Contribuidor de contenido: Abramson Cancer Center of the University of Pennsylvania
Fecha de la última revisión: Octubre 31, 2001

Reviewers: Li Liu, MD
Source: J Urology Volume 164:393-396, (August) 2000

Précis: More extensive biopsy protocol improved prostate cancer detection rate

Introduction

Transrectal ultrasound (TRUS) and TRUS-guided biopsy have become the method of choice for the detection of prostate cancer, especially when curative treatment is planned. In the recent years, a sis biopsy (sextant) protocol has been used by many centers. However, the sextant method may underestimate the presence of cancer. In this study, the researchers evaluated more extensive biopsy protocol in an attempt to improve the detection rate.

Method

A total of 303 patients underwent TRUS-guided biopsy of prostate gland because of elevated prostate-specific antigen (PSA) levels or an abnormal digital rectal examination. At least 10 biopsies were obtained for each patient, including sextant biopsies.

Results
  • The more extensive biopsy protocol improved the detection rate by 6.6% to 38.9% compared with standard sextant biopsies.
  • The complication rate was 1%.
Discussion

In this study, adding peripheral cores to the standard sextant needle biopsies of the prostate significantly improves the cancer detection rate. More extensive biopsy appeared to be well tolerated. The optimal number of samples to be taken and the clinical importance of isoechoic cancer seen on ultrasound have yet to be defined. This study did provide some rational arguments for the decision on an optimal protocol.

Publicaciones de Blog Relacionadas

July 19, 2019

Keeping Controlled Substances Safe in the Home

by OncoLink Team

January 31, 2024

Taking Charge of Your Cancer Care

by Carolyn Vachani, MSN, RN, AOCN

December 29, 2023

Taking Time for the Everyday Things in 2024

by Christina Bach, MSW, LCSW, OSW-C